← All stocks

Armata Pharmaceuticals, Inc.

ARMP Net buying

CIK 0000921114 #4061 in the set updated 22 Sep 2026

Bought (120 mo)

$91.90M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$84.38K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$84.38K

6 of 6 sales

Net

+$91.81M

+$91.81M against sales at will

By person

10 insiders · 19 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Innoviva, Inc. entity

Director

$91.15M (6)

—

+$91.15M

31,230,616

83.99%

$156.15M

+337.0%

COOK JEREMY CURNOCK

Director

$545.33K (4)

—

+$545.33K

411,105

1.11%

$2.06M

+472.2%

PERRY MICHAEL S

Director

$200.00K (3)

—

+$200.00K

411,335

1.11%

$2.06M

+246.4%

KIRK RANDAL J

10% owner

—

$84.38K (6)

−$84.38K

2,169,127

5.83%

$10.85M

+13.1%

Birx Deborah

Chief Executive Officer

—

198,417

0.5336%

$992.09K

—

Salka Michael Scott

Chief Executive Officer

—

11,200

0.0301%

$56.00K

+166.7%

Rychlik Richard

Corporate Controller and PFO

—

10,000

0.0269%

$50.00K

—

Kyme Pierre

Chief Business Officer

—

9,461

0.0254%

$47.31K

−17.9%

Martin Steven Robert

Chief Financial Officer

—

3,760

0.0101%

$18.80K

—

GRINT PAUL C

Chief Executive Officer

—

599

0.0016%

$3.00K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 111

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 8

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 6

Transactions with no price 4

Shares from compensation/vesting 773,570

Sales filed before the plan box existed 6

History held since 16 Nov 2016